Annual Report

Overview

The report describes AFT Pharmaceuticals' return to operating profitability, with total operating revenue of $85.1m and operating profit of $6.1m. It highlights continued international expansion of Maxigesic, including licensing in more than 125 territories and sales in 20 countries. Sustainability disclosures cover community initiatives, supplier risk assessment, environmental packaging efforts, SDG alignment and workforce diversity, including 58% female staff.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: Ends 31 March 2019
Publication date: 21 May 2019
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services